MedPath

Prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage using cilostazol administration with combination enteral and parental nutrition therapy - randomized open-labeled multi-institutional prospective study

Not Applicable
Conditions
Aneurysmal subarachnoid hemorrhage
Registration Number
JPRN-UMIN000031246
Lead Sponsor
Department of Neurosurgery, Kobe University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1.WFNS grade: V 2. New hemorrhage or infarction on computed tomography images one day after surgical intervention 3. Allergy or adverse effect for cilostazol 4. No contraindication of cilostazol according to package medical insert

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath